A Texas judge granted a temporary injunction blocking the state’s ban on hemp-derived delta-8 THC products.
Congress sent President Joe Biden a large-scale infrastructure bill that contains provisions aimed at letting scientists study the actual marijuana that consumers buy from dispensaries—instead of using only government cannabis.
“Americans support legalized marijuana, and now Congress is catching up,” Sen. John Hickenlooper (D-CO), who sponsored the provision, told Marijuana Moment. “When it’s signed into law, our bill is an important step toward researching how we can regulate cannabis-impaired driving safely and accurately.”
A poll found that 62 percent of U.S. adults support the “national legalization of marijuana.” The survey, which shows that 54 percent of Republicans and 68 percent of Democrats are on board, is the second in recent days to show broad public support for ending cannabis prohibition.
Rep. Ed Perlmutter (D-CO) said he would consider adding cannabis banking language to other big pieces of legislation if it doesn’t get enacted through the National Defense Authorization Act.
Mississippi’s House speaker said lawmakers are ready to move on a medical cannabis bill if Gov. Tate Reeves (R) would call a special session.
Kentucky’s Senate Judiciary Committee chairman said he could potentially support a medical cannabis bill in the upcoming session.
The Illinois Supreme Court Commission on Access to Justice posted forms to help people expunge marijuana convictions.
South Dakota activists did not collect enough signatures to qualify a marijuana legalization initiative for the 2022 ballot by the state’s initial deadline, but they believe a federal court ruling gives them more time to keep petitioning.
New Jersey regulators are expected to set a date to begin accepting recreational marijuana business license applications on Tuesday.
New Mexico regulators say they are moving to process marijuana production business licenses as fast as they can, but questions are being raised about whether they will be able to meet the expected April launch of legal sales.
What they found was that consuming marijuana concurrently with substances like psilocybin, LSD, DMT, ayahuasca or mescaline increased the intensity of the trip in a dose-dependent manner.
Use of cannabis together with psychedelics was “associated with higher scores of mystical-type experience, ego-dissolution and visual alterations,” the study, published last week in the journal Psychopharmacology, states. And in general, the more marijuana a person said they used, the more intense the psychedelic effect.
A review of rodent studies suggested “the neuroprotective potential of [cannabis-derived phytocannabinoids] and [resveratrol] for in vivo models of” Parkinson’s disease.
source
